1 day ago
1
- Stifel upgraded IDEXX Laboratories (IDXX) to buy from hold based on expected recurring revenue growth for its Coag Dx analyzer, more vet visits, and continued benefits from the "COVID puppy boom."
- The firm boosted its price target to $700 from $640 (~11% upside based
English (US) ·